Fibator LS Tablet is a combination medication containing Atorvastatin 10mg and Fenofibrate 72.5mg, primarily used to manage dyslipidemia and reduce the risk of cardiovascular disease. Atorvastatin belongs to the statin class of drugs, which work by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis in the liver, thereby lowering low-density lipoprotein (LDL) cholesterol and total cholesterol levels. Fenofibrate, a fibric acid derivative, helps reduce triglycerides and increase high-density lipoprotein (HDL) cholesterol by activating peroxisome proliferator-activated receptors (PPARs), which regulate lipid metabolism. The combination of these two agents provides a comprehensive approach to managing mixed dyslipidemia, especially in patients who do not achieve target lipid levels with monotherapy. Fibator LS is indicated for patients with hypercholesterolemia, hypertriglyceridemia, or mixed dyslipidemia to prevent atherosclerosis and related cardiovascular events such as heart attack and stroke. It should be used under medical supervision, with regular monitoring of liver function, kidney function, and muscle enzymes to detect potential side effects like myopathy or hepatotoxicity. Patients are advised to maintain a healthy diet and lifestyle alongside medication for optimal results.